Results 281 to 288 of about 152,721 (288)

TNM Staging of Cancers of the Head and Neck: Striving for Uniformity Among Diversity†

Ca-A Cancer Journal for Clinicians, 2005
Snehal G Patel, J P Shāh
exaly  

DNA methylation biomarkers for head and neck squamous cell carcinoma

Epigenetics, 2018
Jinyun Li, Hongxia Deng, Zhisen Shen
exaly  

A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)

Annals of Oncology, 2017
D G Pfister, A L Ho, E J Sherman
exaly  

Nuclear factor-kappa B pathway and response in a phase II trial of bortezomib and docetaxel in patients with recurrent and/or metastatic head and neck squamous cell carcinoma

Annals of Oncology, 2010
J Netterville, Y Shyr, B A Murphy
exaly  

HEAD AND NECK SQUAMOUS CELL CARCINOMA ASSAYS

2016
VOGELSTEIN BERT, KINZLER KENNETH W, DIAZ LUIS, PAPADOPOULOS NICKOLAS, AGRAWAL NISHANT, WANG YUXUAN, SPRINGER SIMEON   +6 more
openaire   +4 more sources

Cell kinetics in squamous cell carcinoma of the head and neck

Clinical Otolaryngology, 1992
openaire   +2 more sources

Hiding in plain sight: NUT carcinoma is an unrecognized subtype of squamous cell carcinoma of the lungs and head and neck

Nature Reviews Clinical Oncology
Geoffrey I Shapiro, Christopher A French, Lynette M Sholl   +2 more
exaly  

Head and neck squamous cell carcinomas.

Anti-cancer drugs, 2011
openaire   +1 more source